Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

L. Kappos, M.S. Freedman, C.H. Polman, G. Edan, H.P. Hartung, D. Miller, X. Montalban, F. Barkhof, E.W. Radu, C. Metzig, L. Bauer, V. Lanius, R. Sandbrink, C. Pohl

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)987-997
JournalLancet Neurology
Issue number11
Publication statusPublished - 2009

Cite this